However, the ability of CD44 encoding gene to express multiple isoforms including CD44v, CD44s, and other variants gave the opportunity to identify that CD44v is highly expressed on tumor-capable cells compared to CD44s, while other variants have been identified to be associated with the progression of several cancer types (Mashita et al., 2014; Todaro et al., 2014; Thapa and Wilson, 2016). This evidence concerns the gene CD44 and neoplasm.